The 6 linked references in paper M. Naumtseva S., B. Belov S., E. Aleksandrova N., G. Tarasova M., A. Novikov A., D. Karateev E., E. Luchikhina L., M. Cherkasova V., Yu. Murav'ev V., М. Наумцева С., Б. Белов С., Е. Александрова Н., Г. Тарасова М., А. Новиков А., Д. Каратеев Е., Е. Лучихина Л., М. Черкасова В., Ю. Муравьев В. (2016) “Оценка клинической эффективности, иммуногенности и безопасности 23-валентной пневмококковой вакцины у больных ревматоидным артритом // Assessment of clinical and immunological efficacy and safety of 23-valent pneumococcal vaccine in patients with rheumatoid arthritis” / spz:neicon:pulmonology:y:2015:i:6:p:720-724

  1. Curtis J.R., Yang S., Patkar N.M. et al. Risk of hospitalized bacterial infections associated with biologic treatment among U.S. veterans with rheumatoid arthritis. Arthritis Care Res.2014; 66 (7): 990–997. DOI: 10.1002/acr.22281.
  2. 3–361. DOI: 10.1002/acr.21812. 3. Koivuniemi R., Leirisalo-Repo M., Suomalainen R. et al. Infectious causes of death in patients with rheumatoid arthritis: an autopsy study. Scand. J. Rheumatol. 2006; 35: 273–276. (the paper at Socionet)
  3. Assen S., Agmon-Levin N., Elkayam O. et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann. Rheum. Dis.2011; 70 (3): 414–422. DOI: 10.1136/ard.2010.137216.
  4. Singh J.A., Furst D.E., Bharat A. et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res.2012; 64 (5): 625–639. DOI: 10.1002/ acr.21641.
  5. Rubin L.G., Levin M.J., Ljungman P. et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin. Infect. Dis.2014; 58 (3): e44–100. DOI: 10.1093/cid/cit684.
  6. Lanternier F., Henegar C., Mouthon L. et al. Low influenzavaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann. Rheum. Dis. 2008; 67 (7): 1047. DOI: 10.1136/ard.2007.081703. Наумцева М.С. и др. Оценка клинической эффективности и безопасности 23-валентной пневмококковой вакцины